Multicolored magnetic-laser therapy in asthma patients

H. L. Baradzina, I. M. Lapteva, N. V. Ponachevnaya, V. V. Ulashchyk, I. A. Rybin, S. E. Semizhon (Minsk, Belarus)

Source: Annual Congress 2004 - Biological and clinical effects of asthma therapy
Session: Biological and clinical effects of asthma therapy
Session type: Thematic Poster Session
Number: 3185
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. L. Baradzina, I. M. Lapteva, N. V. Ponachevnaya, V. V. Ulashchyk, I. A. Rybin, S. E. Semizhon (Minsk, Belarus). Multicolored magnetic-laser therapy in asthma patients. Eur Respir J 2004; 24: Suppl. 48, 3185

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effectiveness of combined therapy in patients with brittle asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 512s
Year: 2002

Inhaled antibiotic therapy in patients with severe asthma
Source: Virtual Congress 2021 – Advances in asthma treatment
Year: 2021


Efficacy of ruzam in the treatment of patients with mild-to-moderate asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 131s
Year: 2004

Nonadherence with inhaled preventer therapy in severe asthmatic patients on long-term omalizumab
Source: Eur Respir J, 52 (2) 1801025; 10.1183/13993003.01025-2018
Year: 2018



Real-world treatment patterns of benralizumab therapy for patients with severe asthma
Source: Virtual Congress 2020 – Diagnosis and management of asthma
Year: 2020




Two therapy option in patients with uncontrolled asthma
Source: International Congress 2018 – Physiological and biological insights in asthma
Year: 2018

Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids
Source: Breathe 2010; 6: 365
Year: 2010

Combined therapy of severe osteoporosis for patients with bronchial asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 47s
Year: 2001

Cost of asthma rescue/acute and allergy medications among asthmatic patients on controller therapy
Source: Eur Respir J 2004; 24: Suppl. 48, 344s
Year: 2004

Real-life long-term omalizumab therapy in children with severe allergic asthma
Source: Eur Respir J 2015; 46: 856-859
Year: 2015


Endotypes of severe allergic asthma patients who clinically benefit from Anti-IgE therapy
Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD
Year: 2018


Inhaled corticosteroid therapy on admission of hospitalized patients with COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 243s
Year: 2002

Impact of omalizumab in patients with severe asthma
Source: Annual Congress 2009 - Aspects of uncontrolled asthma
Year: 2009

The effectiveness of nebulizer therapy in the treatment of patients with bronchial asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 424s
Year: 2001

Intermittent therapy with budesonide/formoterol in children with moderate asthma.
Source: International Congress 2017 – Paediatric asthma: therapies and comorbidities
Year: 2017


Adherence to corticosteroids and clinical outcomes in mepolizumab therapy for severe asthma
Source: Eur Respir J, 55 (5) 1902259; 10.1183/13993003.02259-2019
Year: 2020



Add-on omalizumab therapy for patients with severe persistent allergic (IgE-mediated) asthma: identifying which patients to treat and which patients respond
Source: Eur Respir J 2006; 28: Suppl. 50, 440s
Year: 2006

Two-coloured magnetic-laser therapy in sarcoidosis
Source: Eur Respir J 2005; 26: Suppl. 49, 81s
Year: 2005

Extrafine triple therapy in patients with symptomatic COPD and history of one moderate exacerbation
Source: Eur Respir J, 53 (5) 1900235; 10.1183/13993003.00235-2019
Year: 2019



Influence of statin therapy on exacerbation frequency in patients with COPD
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009